The Recall Desk
SevereFDA (Drugs)·D-1165-2022·Announced 2022-07-06

SnoreStop NasoSpray nasal spray recalled for bacterial contamination

SnoreStop NasoSpray nasal spray has been recalled due to bacterial contamination. FDA analysis identified Providencia rettgeri in the product.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I recalls require a minimum severity score of 4 (Severe) per the rubric. This product contains Providencia rettgeri contamination, representing a direct microbial hazard in a non-sterile drug product.

Plain-English summary

SnoreStop NasoSpray, a nasal spray manufactured by Green Pharmaceuticals, Inc., is being recalled nationwide due to microbial contamination. FDA laboratory analysis identified the presence of Providencia rettgeri in the product.

The recalled product is SnoreStop NasoSpray, 0.3 FL OZ (9 mL), NDC 61152-199-99, lot number 2373/21222. Approximately 1074 spray bottles were distributed nationwide within the United States.

Consumers with this product should stop using it immediately and consult a healthcare provider if they have used it.

The recalled product

Product
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3
Manufacturer
Green Pharmaceuticals, Inc.
Category
Drug — Nasal spray
Hazard
  • bacterial-contamination

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot #: 2373/21222

Distribution

Distributed nationwide across the United States.

Related recalls

Same category